Evidence map›Paper›PMID 24289661›Full record

ArticleBMC microbiology2013

Development of a sensitive and specific qPCR assay in conjunction with propidium monoazide for enhanced detection of live Salmonella spp. in food.

Baoguang Li, Jin-Qiang Chen

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Identification and quantification of viableFrontiers in microbiology · 2024
    Article
  5. Advances in detection methods for viable Salmonella spp.: current applications and challenges.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2023
    Review
  6. Detection ofFrontiers in veterinary science · 2022
    Article
  7. Frontiers in environmental science · 2021
    Article
  8. Review
  9. Development of PMAxxFrontiers in microbiology · 2020
    Article
  10. Microcin J25 Exhibits Inhibitory Activity AgainstFrontiers in microbiology · 2020
    Article
  11. Detection of Cell-Dissociated Non-TypeableInternational journal of chronic obstructive pulmonary disease · 2020
    Observational
  12. Evaluating the fate of bacterial indicators, viral indicators, and viruses in water resource recovery facilities.Water environment research : a research publication of the Water Environment Federation · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Presence and Persistence ofFrontiers in public health · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Baoguang LiDivision of Molecular Biology, Center for Food Safety and Applied Nutrition, U,S, Food and Drug Administration, Laurel, MD, 20708, USA. baoguang.li@fda.hhs.gov.
Jin-Qiang Chen
Center for Food Safety and Applied Nutrition · USUnited States Food and Drug Administration · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough a variety of methodologies are available for detection of Salmonella, sensitive, specific, and efficient methods are urgently needed for differentiation of live Salmonella cells from dead cells in food and environmental samples. Propidium monoazide (PMA) can preferentially penetrate the compromised membranes of dead cells and inhibit their DNA amplification, however, such inhibition has been reported to be incomplete by some studies. In the present study, we report an efficient qPCR assay targeting a conserved region of the invA gene of Salmonella in conjunction with PMA treatment for detection of DNA from live Salmonella cells in food samples.

resultsWe investigated the relationship between amplicon length and inhibitory effect of PMA treatment to prevent DNA amplification from dead cells while allowing for DNA amplification from live cells, and found that the two factors are well correlated with each other. An amplicon that is 130 bp in length was determined to be optimal for PMA treatment and was selected for further PMA-qPCR assay development. A PMA-qPCR assay was established by utilizing this amplicon and adopting a modified PMA-treatment procedure. The PMA-qPCR assay provided excellent inhibition of DNA amplification from dead cells (a 17-CT-value, or 128,000-fold reduction) while only a slight DNA amplification difference (0.5 CT value) was noted between the PMA-treated and untreated live cells. This assay has been validated through stringent inclusivity and exclusivity studies using a large number of (n = 167) Salmonella, including all strains of SARA and SARB collections, and non-Salmonella strains (n = 36). This PMA-qPCR assay is capable of detecting live Salmonella cells in live/dead cell mixtures, or 30 CFU/g live Salmonella cells from enriched spiked spinach samples as early as 4 h.

conclusionsA 130-bp amplicon in invA gene was demonstrated to be optimal for PMA treatment for selective detection of live Salmonella cells by PCR. This PMA-qPCR assay provides a sensitive, specific, and efficient method for detecting live Salmonella cells in foods and environmental samples and may have an impact on the accurate microbiological monitoring of Salmonella in foods and environment samples.

Indexed as

Microbial ViabilityAzidesBacterial ProteinsBacteriological TechniquesDNA, BacterialEnzyme InhibitorsFood MicrobiologyPropidiumReal-Time Polymerase Chain ReactionSalmonellaSensitivity and SpecificityAzidesBacterial ProteinsDNA, BacterialEnzyme InhibitorsinvA protein, BacteriaPropidiumpropidium monoazide

Identifiers

PMID24289661
PMCPMC4219372
OpenAlexW2041261896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.